You are here

Vaccinations

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

A more broadly protective coronaviruse vaccine developed by U.S. researchers

https://medicalxpress.com/news/2024-04-broadly-coronavirus-vaccine.html#google_vignette

Researchers develop more broadly protective coronavirus vaccine

Scientists have been searching for the optimal coronavirus vaccine since the COVID-19 pandemic started. The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; however, annually updating those boosters for specific SARS-CoV-2 variants is inefficient for scientists and patients.

SARS-CoV-2 is just one member of the Sarbecovirus (SARS Betacoronavirus) subfamily (others include SARS-CoV-1, which caused the 2002 SARS outbreak, as well as other viruses circulating in bats that could cause future pandemics).

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Mpox vaccine boosters necessary to restore faded protection -- Swedish study

...

Antibody levels fell to low or near zero within the first few months of getting the vaccine, unless the person had previously received a smallpox vaccine, scientists reported Saturday at the European Congress of Clinical Microbiology and Infectious Diseases in Barcelona.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Moderna reports higher immune response for next-generation COVID vaccine

...

The mRNA-1283 vaccine showed a higher immune response—including in seniors—than its currently licensed vaccine, called mRNA-1273.222. Response was higher against Omicron BA.4/BA.5 as well as the original SARS-CoV-2 virus.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Recent studies suggest staying up-to-date on COVID shots helps protect high-risk groups from severe illness

New guidelines suggest certain high-risk groups could benefit from having another dose of a COVID-19 vaccine this spring — and more frequent shots in general — while the broader population could be entering once-a-year territory, much like an annual flu shot.

Medical experts told CBC News that falling behind on the latest shots can come with health risks, particularly for individuals who are older or immunocompromised.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Vaccinations
howdy folks